BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 17257990)

  • 1. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.
    Koster A; Dyke CM; Aldea G; Smedira NG; McCarthy HL; Aronson S; Hetzer R; Avery E; Spiess B; Lincoff AM
    Ann Thorac Surg; 2007 Feb; 83(2):572-7. PubMed ID: 17257990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies.
    Dyke CM; Aldea G; Koster A; Smedira N; Avery E; Aronson S; Spiess BD; Lincoff AM
    Ann Thorac Surg; 2007 Sep; 84(3):836-9. PubMed ID: 17720385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
    Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.
    Mahaffey KW; Lewis BE; Wildermann NM; Berkowitz SD; Oliverio RM; Turco MA; Shalev Y; Ver Lee P; Traverse JH; Rodriguez AR; Ohman EM; Harrington RA; Califf RM;
    J Invasive Cardiol; 2003 Nov; 15(11):611-6. PubMed ID: 14608128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalirudin use in carotid endarterectomy in a patient with heparin-induced thrombocytopenia.
    Finks SW
    Ann Pharmacother; 2006 Feb; 40(2):340-3. PubMed ID: 16449539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia.
    Dyke CM; Koster A; Veale JJ; Maier GW; McNiff T; Levy JH
    Ann Thorac Surg; 2005 Jul; 80(1):299-303. PubMed ID: 15975385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study.
    Smedira NG; Dyke CM; Koster A; Jurmann M; Bhatia DS; Hu T; McCarthy HL; Lincoff AM; Spiess BD; Aronson S
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):686-92. PubMed ID: 16515924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox
    Hassen K; Maccaroni MR; Sabry H; Mukherjee S; Serumadar S; Birdi I
    Perfusion; 2018 Apr; 33(3):235-240. PubMed ID: 28789610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin anticoagulation during cardiac surgery: a single-center experience in 141 patients.
    Koster A; Buz S; Krabatsch T; Yeter R; Hetzer R
    Perfusion; 2009 Jan; 24(1):7-11. PubMed ID: 19567542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.
    Wasowicz M; Vegas A; Borger MA; Harwood S
    Can J Anaesth; 2005 Dec; 52(10):1093-8. PubMed ID: 16326682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of bivalirudin for combined carotid endarterectomy and coronary revascularization with the use of cardiopulmonary bypass in a patient with an elevated heparin-platelet factor 4 antibody titer.
    Avery EG; Hilgenberg AD; Cambria RP; Beckerly R; Donnelly AM; Laposata M
    Anesth Analg; 2009 Apr; 108(4):1113-5. PubMed ID: 19299772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia.
    Clayton SB; Acsell JR; Crumbley AJ; Uber WE
    Ann Thorac Surg; 2004 Dec; 78(6):2167-9. PubMed ID: 15561064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalirudin for patients with heparin-induced thrombocytopenia undergoing cardiovascular surgery.
    Czosnowski QA; Finks SW; Rogers KC
    Ann Pharmacother; 2008 Sep; 42(9):1304-9. PubMed ID: 18682541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Gurm HS; Smith DE; Chetcuti SJ; Share D; Khanal S; Riba A; Carter AJ; Lalonde T; Kline-Rogers E; O'Donnell M; O'Neill W; Safian R; Moscucci M;
    J Interv Cardiol; 2007 Jun; 20(3):197-203. PubMed ID: 17524111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalirudin: alternative anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
    Grubb KJ; Salehi P; Chedrawy EG
    Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):20-4. PubMed ID: 19903167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.
    Kiser TH; Burch JC; Klem PM; Hassell KL
    Pharmacotherapy; 2008 Sep; 28(9):1115-24. PubMed ID: 18752382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement.
    Faella KH; Whiting D; Fynn-Thompson F; Matte GS
    J Extra Corpor Technol; 2016 Mar; 48(1):39-42. PubMed ID: 27134308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case 1-2006: off-pump coronary artery bypass graft surgery anticoagulation with bivalirudin: a patient with heparin-induced thrombocytopenia syndrome type II and renal failure.
    Spiess BD; DeAnda A; McCarthy HL; Yeatman D; Katlaps G; Cooper C; Koster A; Aldea GS; Gravlee GP
    J Cardiothorac Vasc Anesth; 2006 Feb; 20(1):106-11. PubMed ID: 16458228
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac transplantation and/or mechanical circulatory support device placement using heparin anti-coagulation in the presence of acute heparin-induced thrombocytopenia.
    Zucker MJ; Sabnani I; Baran DA; Balasubramanian S; Camacho M
    J Heart Lung Transplant; 2010 Jan; 29(1):53-60. PubMed ID: 19819167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.